Page last updated: 2024-08-22

butylhydroxybutylnitrosamine and Hormone-Dependent Neoplasms

butylhydroxybutylnitrosamine has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalgo, ML; He, Y; Hooker, E; Johnson, DT; Luong, R; Sun, Z; Yu, EJ1
Izumi, K; Li, Y; Miyamoto, H1

Reviews

1 review(s) available for butylhydroxybutylnitrosamine and Hormone-Dependent Neoplasms

ArticleYear
The role of the androgen receptor in the development and progression of bladder cancer.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:7

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Castration; Disease Models, Animal; Disease Progression; Evidence-Based Medicine; Female; Gene Expression Regulation, Neoplastic; Humans; Incidence; Male; Neoplasms, Hormone-Dependent; Receptors, Androgen; Risk Factors; Sex Factors; Signal Transduction; Urinary Bladder Neoplasms

2012

Other Studies

1 other study(ies) available for butylhydroxybutylnitrosamine and Hormone-Dependent Neoplasms

ArticleYear
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Cell Transformation, Neoplastic; Drug Implants; Female; Genetic Predisposition to Disease; Humans; Integrases; Male; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orchiectomy; Promoter Regions, Genetic; Receptors, Androgen; Recombinant Fusion Proteins; Tamoxifen; Testosterone; Transgenes; Urinary Bladder Neoplasms; Uroplakin III

2016